| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Hameln Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, Glenmark Pharmaceuticals Nordic AB, Øresund Pharma ApS, Sandoz A/S, Orifarm A/S, Paranova Danmark A/S, Vingmed A/S, Abacus Medicine A/S, Paranova Danmark A/S | 148.085.649 kr. | 13. oktober 2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Hameln Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, Glenmark Pharmaceuticals Nordic AB, Øresund Pharma ApS, Sandoz A/S, Orifarm A/S, Paranova Danmark A/S, Vingmed A/S, Abacus Medicine A/S, Paranova Danmark A/S | 148.085.649 kr. | 13. oktober 2026 |
| Amgros 2027 1.1205.b | Amgros I/S | Hameln Pharma ApS, Orifarm A/S, Abcur AB, Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS | 43.986.317 kr. | 13. oktober 2026 |